ABSTRACT

References..................................................................................................................................... 481

As more and more therapies for both rheumatoid arthritis (RA) and osteoarthritis (OA) become

available, there is increased demand to evaluate both their appropriateness, and then their

effectiveness on individual patients. As a result, the role of imaging in assessing and monitoring

disease progress is on the rise, and is expected to grow significantly in the near future.